Characterization of RNA‐binding motif 3 (RBM3) protein levels and nuclear architecture changes in aggressive and recurrent prostate cancer
Abstract
The RNA‐binding motif protein 3 (RBM3) has been shown to be upregulated in several types of cancer, including prostate cancer (PCa), compared with normal tissues. Increased RBM3 nuclear expression has been linked to improved clinical outcomes.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 29, 2020
- Source ID
- 10.1002/cnr2.1237
Entities
People
- Christine Davis
- Guangjing Zhu
- M. Craig Miller
- Neil M Carleton
- Prakash Kulkarni
- Robert W. Veltri
Organizations
- City of Hope National Medical Center
- Johns Hopkins University
- National Cancer Institute
- National Center for Research Resources
- Prostate Cancer Foundation
- United States Department of Defense